Sumitomo Mitsui Trust Holdings, Inc. Amgen Inc Transaction History
Sumitomo Mitsui Trust Holdings, Inc.
- $145 Billion
- Q4 2024
A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 1,594,828 shares of AMGN stock, worth $501 Million. This represents 0.29% of its overall portfolio holdings.
Number of Shares
1,594,828
Previous 1,575,775
1.21%
Holding current value
$501 Million
Previous $508 Million
18.13%
% of portfolio
0.29%
Previous 0.36%
Shares
31 transactions
Others Institutions Holding AMGN
# of Institutions
3,183Shares Held
418MCall Options Held
8.25MPut Options Held
6.39M-
Vanguard Group Inc Valley Forge, PA52.7MShares$16.6 Billion0.25% of portfolio
-
Black Rock Inc. New York, NY46MShares$14.5 Billion0.33% of portfolio
-
State Street Corp Boston, MA29.4MShares$9.25 Billion0.31% of portfolio
-
Morgan Stanley New York, NY14.6MShares$4.58 Billion0.27% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA13.2MShares$4.15 Billion0.65% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $168B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...